Pre-earnings options volume in Regencell Bioscience (RGC) Holdings Ltd is 1.1x normal with calls leading puts 8:5. Implied volatility suggests the market is anticipating a move near 42.1%, or 0c, after results are released. Median move over the past eight quarters is 14.3%.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RGC:
- What Triggered the Wild 120% Rally in Regencell Bioscience Stock (RGC)?
- Regencell Bioscience Holdings Ltd trading resumes
- Regencell Bioscience Holdings Ltd trading halted, volatility trading pause
- Six new option listings and two option delistings on July 1st
- Regencell Bioscience Reports Improved Financial Results for First Half of 2025